Author

L. Havlicek

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1

Frequent Co-Authors

E. Reznickova· 1 shared J. Skerlova· 1 shared M. Kovalova· 1 shared M. Perina· 1 shared P. Rezacova· 1 shared R. Jorda· 1 shared S. Djukic· 1 shared T. Pospisil· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

E. Reznickova

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivFeb 24, 2023

Characterization of new highly selective pyrazolopyrimidine inhibitor of CDK7

M. Kovalova, L. Havlicek, S. Djukic…·V. Krystof

This paper characterizes a new CDK7 inhibitor, LGR6768, showing nanomolar potency and selectivity, with structural and cellular evidence supporting its mechanism and therapeutic potential.

DOI 10.1016/j.biopha.2023.114492

experimental assaydrug response / drug discovery

𝕏 PostBluesky